Equities

Shenzhen YHLO Biotech Co Ltd

688575:SHH

Shenzhen YHLO Biotech Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)21.27
  • Today's Change2.71 / 14.60%
  • Shares traded1.38m
  • 1 Year change-8.32%
  • Beta1.1864
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments7081,393490
Total Receivables, Net473424276
Total Inventory635570364
Prepaid expenses336943
Other current assets, total2.96405.65
Total current assets1,8512,4951,178
Property, plant & equipment, net1,3711,044672
Goodwill, net5.295.29--
Intangibles, net201217105
Long term investments27731975
Note receivable - long term----3.76
Other long term assets------
Total assets3,8064,2122,138
LIABILITIES
Accounts payable223321142
Accrued expenses15726561
Notes payable/short-term debt202304172
Current portion long-term debt/capital leases1.075.054.73
Other current liabilities, total257639133
Total current liabilities8411,534512
Total long term debt38518978
Total debt589498255
Deferred income tax9.06140.02
Minority interest(26)28(11)
Other liabilities, total373033
Total liabilities1,2461,795612
SHAREHOLDERS EQUITY
Common stock568567405
Additional paid-in capital432390525
Retained earnings (accumulated deficit)1,5461,446596
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total1414(0.12)
Total equity2,5602,4171,526
Total liabilities & shareholders' equity3,8064,2122,138
Total common shares outstanding568567567
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.